Compare VOR & EFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | EFOR |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2021 | 1996 |
| Metric | VOR | EFOR |
|---|---|---|
| Price | $22.35 | $31.44 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $45.33 | N/A |
| AVG Volume (30 Days) | ★ 697.7K | 586.5K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $3,980,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $63.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.50 | $16.90 |
| 52 Week High | $49.95 | $33.78 |
| Indicator | VOR | EFOR |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 50.20 |
| Support Level | $21.90 | $16.94 |
| Resistance Level | $24.44 | $33.53 |
| Average True Range (ATR) | 1.13 | 1.56 |
| MACD | -0.19 | -0.57 |
| Stochastic Oscillator | 12.44 | 11.31 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Everforth Inc is a technology and digital engineering company that helps organizations adapt, innovate, and thrive in a world of constant change. It has six solution areas: AI & data, cloud and infrastructure, digital engineering, customer experience, cybersecurity, and enterprise platforms - accelerate time to value for commercial and federal clients.